Małolepsza-Jarmołowska K, Kubis A A, Hirnle L
Department of Pharmaceutical Technology, Faculty of Pharmacy, Wrocław Medical University, Wrocław, Poland.
Pharmazie. 2003 Apr;58(4):260-2.
Intravaginal tablets based on hydrophilic methylcellulose and containing lactic acid complexed with Eudragit E-100 undergo deformation under standard conditions. The high flow--limit of gel originating from the tablets as well as its dynamic viscosity should enable durability of this dosage form on the vaginal mucosa. By selecting either 1 : 1 or 2 : 1 ratios of lactic acid to Eudragit E-100 it is possible to obtain tablets that disintegrate into a gelform at pH 3.8-4.4, i.e. the pH remains within the physiological range. Increasing the amount of lactic acid in the complex in relation to the polymer to a 4:1 ratio results in gels with a lower pH while possessing an acid reserve that can neutralize the excess of alkali present in severe vaginal infections.
基于亲水性甲基纤维素且含有与Eudragit E - 100络合的乳酸的阴道内片剂在标准条件下会发生变形。片剂产生的凝胶的高流动极限及其动态粘度应能使该剂型在阴道粘膜上保持耐久性。通过选择乳酸与Eudragit E - 100的比例为1:1或2:1,有可能获得在pH 3.8 - 4.4时崩解成凝胶形式的片剂,即pH保持在生理范围内。相对于聚合物,将络合物中乳酸的量增加到4:1的比例会产生pH较低的凝胶,同时具有可以中和严重阴道感染中存在的过量碱的酸储备。